Results 211 to 220 of about 73,761 (306)
RGD-HSA-TAC nanoparticles targeted delivery of tacrolimus and attenuation of podocyte injury in diabetic kidney disease. [PDF]
J NanobiotechnologyGuo Z +10 more
europepmc +1 more source
Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus-Induced Nephrotoxicity Through Targeting the miR-22/HMGB-1/TLR4/MyD88/NF-κB Trajectory. [PDF]
Arch Pharm (Weinheim)Abdelhady R +6 more
europepmc +1 more source
Corrigendum: Population dynamics analysis of the interaction between tacrolimus and voriconazole in renal transplant recipients. [PDF]
Front PharmacolSun ZH +6 more
europepmc +1 more source
Population dynamics analysis of the interaction between tacrolimus and voriconazole in renal transplant recipients. [PDF]
Front PharmacolSun ZH +6 more
europepmc +1 more source
POSSIBLE TACROLIMUS ACTION MECHANISMS IN ITS PROTECTOR EFFECTS ON ISCHEMIA-REPERFUSION INJURY
, 1998 Francisco Javier García‐Criado +7 more
openalex +1 more source
Clinical characteristics and treatment outcomes of linear IgA bullous dermatosis
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Linear immunoglobulin A (IgA) bullous dermatosis (LABD), also referred to as chronic bullous disease of childhood (CBDC), is characterized by the linear deposition of IgA antibodies within the dermal‐epidermal junction. While dapsone is typically recommended, alternative modalities may be considered based on accessibility, severity, and prior ...
Kristie Mar +7 more
wiley +1 more source